CXCL1 and metabolic dysfunction-associated steatotic liver disease: This decrease in CXCL1 levels was further confirmed using quantitative reverse transcription polymerase chain reaction (RT-qPCR) in hepatocytes of NAFLD of AlbSmad4−/− mice (Fig. 3C).